Overexpression of P-gp was detected in about 50% of patients with chronic myelogenous leukemia (CML) unresponsive to chemotherapy with Vinca alkaloids and anthracyclines (Kuwazuru et al., 1990). Here, PGP is linked to chronic myelogenous leukemia, BCR-ABL1 positive.